SIRT1 and cancer: The influence of SIRT1 on antimicrobial defense against infection has yet to be reported but is important to define, particularly since SIRT1 inhibitors are being investigated as therapeutic agents for the treatment of Huntington’s disease and cancer ([22–25]; clinical trials NCT01521832 and NCT01521585).